Chinese english Germany Japanese Korea

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Struktur
2626934-45-8
CAS-Nr.
2626934-45-8
Englisch Name:
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
Synonyma:
Mansonone G;Avatrapa impurity 1;Avatroposide impurities6;Avatrombopag Impurity 17 HCl;3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-;5-chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide;5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity)
CBNumber:
CB38993787
Summenformel:
C25H30Cl2N6OS2
Molgewicht:
565.58
MOL-Datei:
2626934-45-8.mol
Request For Quotation

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Eigenschaften

Dichte
1.398±0.06 g/cm3(Predicted)
pka
4.49±0.70(Predicted)

Sicherheit

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 20)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
China National Standard Pharmaceutical Corporation Limited 		+8615391658522
 overseasales@yongstandards.com China 11927 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+86-0755-22677845 +86-13627253706
 sale@hdimpurity.com China 2092 58
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-52878169 15701683040
 sales@bjcomparison.com China 4701 58
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
 2880679888@qq.com China 2740 58
Shenzhen Botel Biotechnology Co. Ltd. 0755-22202135 13316968096
 1979313431@qq.com China 7898 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 17825480238
 3008233717@qq.com China 9843 12
Shanghai Xinlitai Pharmaceutical Co. , Ltd. 18616665298
 wenjie.li@bocimed.com China 226 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
 sales@reading-chemicals.com China 14092 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
 2853117764@qq.com China 8645 58
Guangzhou Juntang Technology Co., Ltd 020-36607679 13502246435
 sales@dmstandards.com China 10951 58
  • 3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
  • Avatrombopag Impurity 17 HCl
  • 5-chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide
  • Avatroposide impurities6
  • Avatrapa impurity 1
  • Mansonone G
  • 5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity)
  • 2626934-45-8
  • C25H30Cl2N6OS2
Copyright 2019 © ChemicalBook. All rights reserved